Page last updated: 2024-08-21

nicotinamide mononucleotide and Carcinoma

nicotinamide mononucleotide has been researched along with Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Borrelli, M; Kahn, B; Libby, T1

Reviews

1 review(s) available for nicotinamide mononucleotide and Carcinoma

ArticleYear
A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction.
    Journal of drugs in dermatology : JDD, 2022, Oct-01, Volume: 21, Issue:10

    Topics: Carcinoma; Humans; Keratinocytes; NAD; Niacinamide; Nicotinamide Mononucleotide; Pyridinium Compounds; Risk Reduction Behavior

2022